| Ticker | AXNX |
|---|---|
| ISIN | US05465P1012 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and ...
Axonics, Inc. opera en el sector Healthcare, industria Medical - Devices.